Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
39 Results for "
Fmoc solid phase peptide synthesis
" in MedChemExpress (MCE) Product Catalog:
Products (39)
39 Results for "Fmoc solid phase peptide synthesis" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-W010712
CAS No.: 109425-51-6
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-W013081
CAS No.: 132327-80-1
Cat. No.: HY-Y1636
CAS No.: 154445-77-9
Research Areas:
Cat. No.: HY-W002327
CAS No.: 132388-59-1
Cat. No.: HY-W008558
CAS No.: 103478-62-2
Target:
Research Areas:
Fmoc-N-Me-Leu-OH is an N-Fmoc-N-methyl amino acid that can be used in peptide coupling reactions. Fmoc-N-Me-Leu-OH is primarily used as a standard building block in solid-phase peptide synthesis (SPPS) to introduce N-methylleucine residues into peptide chains, thereby enhancing the enzymatic stability, altering conformational flexibility, and modifying the biological activity of the target peptide .
Cat. No.: HY-Y0912
CAS No.: 94790-37-1
Synonyms: N-HBTU
Target:
Research Areas:
HBTU (N-HBTU) is a guanidinium-based peptide coupling reagent and immunological sensitizer. HBTU can be used in combination with bases such as DIPEA (HY-130142) to complete coupling reactions, with HOBt and TMU as by-products. HBTU is a standard reagent in automated solid-phase peptide synthesis, particularly for the Fmoc/tBu strategy, which effectively promotes coupling steps, but it is not suitable for sterically hindered amino acids or dipeptide derivatives. HBTU can induce rhinitis, dermatitis, bronchial asthma and severe allergic reactions. HBTU can be used to study the pathogenesis of allergic reactions, occupational rhinitis, allergic contact dermatitis and bronchial asthma .
Synonyms: Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH; Fmoc-Ser[GalNAc(Ac)3-α-D]-OH; Fmoc-Ser(Ac3AcNH-α-Gal)-OH
Research Areas:
Fmoc-Ser (O-α-D-GalNAc (OAc) 3)-OH (Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH) is a protected glycosylated amino acid and Tn antigen. Fmoc-Ser (O-α-D-GalNAc (OAc) 3)-OH serves as a building block in the solid-phase synthesis of Tn-based cancer vaccine constructs. Fmoc-Ser (O-α-D-GalNAc (OAc) 3)-OH supports solid-phase peptide synthesis .
Cat. No.: HY-W072147
CAS No.: 82911-78-2
Synonyms: Fmoc-L-Ser-OMe
Research Areas:
Cat. No.: HY-W008235
CAS No.: 84000-07-7
Research Areas:
Fmoc-N-Me-Ala-OH is an Fmoc-protected N-methyl-L-alanine and also a building block for solid-phase peptide synthesis. As a building block, Fmoc-N-Me-Ala-OH is used to synthesize peptidomimetic antagonists of XIAP BIR3 derived from Smac/DIABLO .
Cat. No.: HY-W010922
CAS No.: 162558-25-0
Research Areas:
Cat. No.: HY-W111226
CAS No.: 252049-16-4
Target:
Research Areas:
Cat. No.: HY-W013154
CAS No.: 136030-33-6
Target:
Research Areas:
Fmoc-Tic-OH, an Fmoc-protected derivative of Tic, is a solid-phase peptide synthesis monomer. Fmoc-Tic-OH protects the amino group of Tic via a base-labile Fmoc group, allowing conformationally constrained Tic residues to be stepwise coupled to peptide chains, and the Fmoc protecting group can be removed under piperidine conditions. Fmoc-Tic-OH can be used for peptide synthesis and opioid receptor ligand research .
Cat. No.: HY-164732
CAS No.: 1611478-62-6
Target:
Research Areas:
Fmoc-Lys (DOTA)-OH is an Fmoc-protected Lysine derivative with metal-chelating properties, containing the macrocyclic chelator DOTA. Fmoc-Lys (DOTA)-OH undergoes metallation with Tb or Lu. Fmoc-Lys (DOTA)-OH utilizes metal coordination to protect the carboxyl groups of DOTA. Fmoc-Lys (DOTA)-OH can be used in solid-phase peptide synthesis research .
Cat. No.: HY-151748
CAS No.: 1994267-98-9
Target:
Research Areas:
N3-L-Orn(Fmoc)-OH is a non-natural amino acid building block specially designed for solid-phase peptide synthesis and click chemistry. N3-L-Orn(Fmoc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
Cat. No.: HY-Y1636S
CAS No.: 1217461-89-6
Cat. No.: HY-179477
Research Areas:
Fmoc-β-Ala-Asp(OMpe)-OH is a specialized amino acid derivative used in solid-phase peptide synthesis (SPPS). Fmoc-β-Ala-Asp(OMpe)-OH consists of a beta-alanine spacer linked to an aspartic acid residue, where the beta-carboxyl group is protected with a 3-methylpentyl ester (OMpe) to prevent aspartimide formation during synthesis. Fmoc-β-Ala-Asp(OMpe)-OH a useful building block for creating peptides that contain aspartic acid, as the OMpe group is designed to minimize unwanted side reactions .
Synonyms: L-azidovaline CHA
Target:
Research Areas:
N3-L-Val-OH (L-azidovaline) (CHA) is a mixture of N3-L-Val-OH and Cyclohexanamine. N3-L-Val-OH is a non-natural amino acid building block specifically designed for solid-phase peptide synthesis and click chemistry. N3-L-Orn(Fmoc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
Cat. No.: HY-W010756
CAS No.: 126828-35-1
Target:
Research Areas:
FMOC-AM is a derivative of aminomethyl resin. FMOC-AM provides a solid-phase carrier basis for peptide chain synthesis and can be used in solid-phase peptide synthesis .
Cat. No.: HY-151843
CAS No.: 473430-12-5
Target:
Research Areas:
N3-L-Lys(Fmoc)-OH is a non-natural amino acid building block specially designed for solid-phase peptide synthesis and click chemistry. N3-L-Lys(Fmoc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
Cat. No.: HY-W013081S
CAS No.: 1217462-20-8
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
